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Premature Cardiac Aging in South Asian Compared to Afro-Caribbean
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Background-—People of South Asian (SAs) and African Caribbean (AC) origin have increased cardiovascular morbidity, but
underlying mechanisms are poorly understood. Aging is the key predictor of deterioration in diastolic function, which can be
assessed by echocardiography using E/e0 ratio as a surrogate of left ventricular (LV) ﬁlling pressure. The study aimed to assess a
possibility of premature cardiac aging in SA and AC subjects.
Methods and Results-—We studied 4540 subjects: 2880 SA and 1660 AC subjects. All participants underwent detailed
echocardiography, including LV ejection fraction, average septal-lateral E/e0, and LV mass index (LVMI). When compared to ACs,
SAs were younger, with lower mean LVMI, systolic blood pressure (BP), diastolic BP, and body mass index (BMI), as well as a lower
prevalence of hypertension and smoking (P≤0.001 for all). In a multivariate linear regression model including age, sex, ethnicity, BP,
heart rate, BMI, waist circumference, LVMI, history of smoking, hypertension, coronary artery disease, diabetes mellitus,
medications, SA origin was independently associated with higher E/e0 (regression coefﬁcientstandard error, 0.660.10;
P<0.001, adjusted R2 for the model 0.21; P<0.001). Furthermore, SAs had signiﬁcantly accelerated age-dependent increase in E/e0
compared to ACs. On multivariable Cox regression analysis without adjustment for E/e0, SA ethnicity was independently predictive
of mortality (P=0.04). After additional adjustment for E/e0, the ethnicity lost its signiﬁcance value, whereas E/e0 was independently
predictive of higher risk of death (P=0.008).
Conclusions-—Premature cardiac aging is evident in SAs and may contribute to high cardiovascular morbidity in this ethnic group,
compared to ACs. ( J Am Heart Assoc. 2016;5:e004110 doi: 10.1161/JAHA.116.004110)
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S outh Asians (SAs) comprise one quarter of the world’spopulation and represent a major minority ethnic group in
many Western countries. Both native and migrant SAs have a
high prevalence of cardiovascular disease and increased
cardiovascular mortality.1–5 This is partly attributable to high
frequency of cardiovascular risk factors, particularly diabetes
mellitus.6 In the UK, SAs have a higher risk of coronary artery
disease (CAD), compared to white Europeans, but an opposite
trend is observed in people of African-Caribbean (AC) origin.7
Of note, excess in cardiac morbidity in SAs is evident despite
adjustment for conventional cardiovascular risk factors, and
they typically present with heart failure and require coronary
interventions at a younger age compared to white subjects.8,9
Also, the Framingham score, which developed in the white US
population, failed to predict excess in cardiovascular mortality
in SAs in the UK.10,11 Initially, this was deemed attributable to
lack of socioeconomic adjustment in the score.12 However, a
new QRISK2 score developed in the UK that accounts for
deprivation was equally unreliable in ethnic minority groups.13
Whereas the Framingham score underestimates risk among
SAs, it overestimates outcome in the AC community, thus
indicating intrinsic ethnic differences in prognostication
beyond conventional risk factors.13
E/e0, a ratio of peak early diastolic mitral ﬂow velocity and
peak early diastolic mitral annulus tissue velocity, has been
established as a noninvasive surrogate for left ventricular (LV)
diastolic pressures.14 E/e0 is widely used for grading LV
diastolic function, and it has been uniformly shown to be
reproducible in daily practice.15 Numerous clinical studies
have produced convincing evidence of a positive, linear
relation of E/e0 and invasively measured mean LV diastolic
pressure regardless of heart rhythm, heart rate, and LV
ejection fraction (LVEF).16–21 Indeed, E/e0 was more accurate
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than natriuretic peptides for noninvasively determining LV
diastolic pressures.20 Also, E/e0 parallels changes in LV
diastolic pressures during exercise.22
In addition to its relationship with ﬁlling pressure, E/e0 has
a clear association with aging, even in healthy individuals, and
can serve as a surrogate measure of cardiac aging.23–25
However, no information is currently available on differences
of age-related changes in E/e0 and presence of accelerated
ageing in ethnic minority groups, as well as its role in
prognostication.
The Ethnic-Echocardiographic Heart of England Screening
Study (E-ECHOES) study was a cross-sectional population
survey of subjects of SA origin (ie, from India, Pakistan, or
Bangladesh) and AC origin age ≥45 years.26 Study individuals
were recruited from September 2006 to August 2009 from 20
primary care centers in Birmingham, UK, and the collected
data included comprehensive clinical assessment and
echocardiography.26 In the present ancillary analysis to the
E-ECHOES study, we assessed the presence of accelerated
cardiac aging in SAs using E/e0 as a surrogate and its role in
all-cause mortality, compared to AC subjects.
Methods
The analysis was performed using the E-ECHOES study
population. Exclusion criteria were conditions known to affect
utility of E/e0 ratio as an estimate of LV ﬁlling pressure: (1)
moderate-severe aortic or mitral valve disease (stenosis or
regurgitation), signiﬁcant cardiac dyssynchrony attributed to
LV conduction abnormalities (ie, QRS ≥140 ms). The analysis
only included patients who had no missing data in the
parameters used to establish the regression model described
below. The E-ECHOES database has 5353 entries, of whom
813 met the exclusion criteria and 4540 patients have been
included in the analysis.
The vast majority of the study participants were ﬁrst-
generation migrants who lived most of their life in the UK.
Among the 2880 South Asian patients, 2625 (91%) were born
in India, Pakistan, or Bangladesh, only 50 (1.7%) were born in
the UK, with the rest (205; 7%) of the patients born in other
parts of the world (mostly from East Africa). Mean age of
settling in the UK was 2613 years, and mean duration since
coming to the UK was 3512 years. Among the 1660
participants of AC origin, 1293 (78%) were born in the
Caribbean islands (majority, 1104 [67%] in Jamaica), 291
(18%) in the UK, and 76 (5%) in other countries. Mean age of
settling in the UK was 2312 years, and mean duration since
coming to the UK was 4114 years.
The E-ECHOES study was approved by Walsall Local
Research Ethics Committee (05/Q2708/45), with all partic-
ipants having provided written informed consent for data
collection and analysis. Cases of deaths and their causes
were provided by the Ofﬁce of National Statistics.
Echocardiography
All study participants underwent detailed echocardiographic
analysis with images reviewed by a consultant cardiologist
with expertise in echocardiography. Echocardiography was
done in primary care settings using a portable VIVID i machine
(GE Healthcare, Chalfont St Giles, UK). LVEF, dimensions of
cardiac chambers, LV mass index (LVMI), and parameters of
diastolic function (mitral valve E/A ratio; E-wave deceleration
time; and isovolumic relaxation time, tissue Doppler imaging
of lateral, and septal mitral valve annulus) were also measured
in accord with current recommendations.27 An average of
septal and lateral E/e0 was calculated and used in the
analysis.
Statistical Analysis
Descriptive data are presented as median (interquartile range;
IQR) and compared using the Kruskal–Wallis test. Linear
regression was used to establish predictors of E/e0 and left
atrial diameter index (LADI) with the following predictor
variables tested: age, sex, history of diabetes mellitus and
smoking, systolic and diastolic blood pressure (BP), heart rate,
body mass index (BMI), waist circumference, and LVMI. Cox
regression analysis was used to establish predictors of all-
cause mortality in the study population using the predictor
variables above. P values of <0.05 were considered as
statistically signiﬁcant. STATA software (version 13; StatCorp
LP, College Station, TX) was used for statistical analyses.
Results
Demographic characteristics of participants reﬂect distribu-
tion of ethnic minority groups in Birmingham (Table 1). When
compared to ACs, SAs were younger, had lower systolic BP,
diastolic BP, and BMI, as well as lower prevalence of
hypertension and smoking (P≤0.001 for all). Diabetes mellitus
was more common in SAs (30% vs 27%; P=0.005). Calcium-
channel blockers and diuretics were more often used in ACs
(P<0.001 for both). Consistently with lower rates of hyper-
tension and blood pressure values, SAs had lower LVMI (117
[93–143] vs 103 [85–125] g/m2 in ACs). ACs and SAs had
similar low rates of reduced LVEF (<55%; 2% in both groups),
and E/e0 was nonsigniﬁcantly different from ACs (P=0.85) in a
nonunadjusted analysis.
The strongest predictors of E/e0 on multivariable regres-
sion analysis were high systolic BP (standardized b=0.22),
advanced age (standardized b=0.20), higher LVMI
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(standardized b=0.19), and SA ethnicity (standardized
b=0.10; P<0.001 for all; adjusted R2 for the model, 0.21;
Table 2). Relationship between age and E/e0 was polynomial
with linear (F statistics, 124; P<0.001) and quadratic (F
statistics, 22; P<0.001) components. On polynomial regres-
sion, SA ethnicity was associated with higher E/e0 for the
whole model and for all age groups presented (P<0.001 for all;
Figure 1).
There was a signiﬁcant interaction between age and
ethnicity in their relation to E/e0 (standardized b=0.36 for
interaction; P<0.001; Figure 2). This interaction is suggestive
that SA had a steeper age-related increase in adjusted
regression slope of age-E/e0 relationship. Based on the
adjusted model, E/e0=8 is reached at age 46.3 years in SAs
and at 53.4 years in ACs (ie, 7.1-year difference with South
Asians). Further increase in 1 unit of E/e0 (ie, E/e=9) was
reached at age 62.7 years in SAs and at 78.1 years in ACs (ie,
15.4 years later).
The model was additionally tested for possible interactions
between ethnicity and presence of diabetes or CAD, but no
such signiﬁcant interactions were found (standardized
b=0.04; P=0.10 for diabetes mellitus; standardized
b=0.03; P=0.32 for CAD). In this model, interactions
between SA ethnicity and age remain highly signiﬁcant
(standardized b=0.42; P<0.001), supporting the presence of
accelerated E/e0 increase in this ethnic group. The role of
Table 1. Demographic Characteristics of the Study Population
South Asians (n=2880) African Caribbeans (n=1660) P Value
Demographic and clinical characteristics
Age, y 56 [51–66] 61 [50–72] <0.001
Male 1380 [48%] 747 [44%] 0.02
SBP, mm Hg 138 [126–152] 143 [131–157] <0.001
DBP, mm Hg 81 [74–88] 82 [75–90] 0.001
Heart rate, bits/min 78 [70–87] 76 [68–85] <0.001
BMI, kg/m2 28 [25–31] 29 [26–33] <0.001
Waist circumference, cm 97 [90–104] 97 [88–105] 0.58
Hypertension, n 1254 [44%] 944 [57%] <0.001
CAD, n 311 [11%] 86 [5%] <0.001
Diabetes mellitus, n 878 [30%] 441 [27%] 0.005
History of heart failure 25 [1%] 18 [1%] 0.47
Chronic obstructive pulmonary disease, n 25 [1%] 15 [1%] 0.90
AF, n 17 [1%] 14 [1%] 0.32
History of smoking, n 653 [23%] 721 [43%] <0.001
Medications
Angiotensin conversion enzyme inhibitors or
angiotensin receptor antagonists, n
651 [23%] 391 [24%] 0.46
Calcium-channel blockers, n 487 [17%] 599 [36%] <0.001
Aldosterone antagonists, n 280 [10%] 180 [11%] 0.23
Beta-blockers, n 370 [13%] 199 [12%] 0.40
Diuretics, n 475 [16%] 506 [30%] <0.001
Echocardiographic data
Reduced ejection fraction <55% 70 [2%] 34 [2%] 0.41
E/e0 ratio 8.0 [6.3–10.2] 8.0 [6.5–9.9] 0.85
LVMI, g/m2 103 [85–125] 117 [93–143] <0.001
End-diastolic diameter index, cm/m2 2.46 [2.26–2.69] 2.37 [2.17–2.59] <0.001
LADI, cm/m2 1.73 [1.55–1.91] 1.65 [1.46–1.85] <0.001
Diastolic dysfunction, n 1683 [59%] 1023 [62%] 0.03
AF indicates atrial ﬁbrillation; BMI, body mass index; CAD, coronary artery disease; DBP, diastolic blood pressure; LADI, left atrial diameter index; LVMI, left ventricular mass index; SBP,
systolic blood pressure.
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ethnicity in predicting E/e0 was further tested in separate
subgroups of subjects with and without diabetes mellitus and
CAD. Independent association of SA ethnicity with higher E/e0
was evident in all 4 subgroups (Table 3). Analysis of
interactions between ethnicity and age in patients had limited
power in patients with diabetes mellitus (n=441 for AC
patients with diabetes mellitus and n=86 of AC patients with
CAD), especially given the ethnic difference in age distribu-
tions. Interactions between SA ethnicity and age were highly
signiﬁcant in subjects without diabetes mellitus (standardized
b=0.39; P<0.001) and without CAD (standardized b=0.42;
P<0.001), but such interactions were not signiﬁcant in
patients with diabetes mellitus (standardized b=0.21;
P=0.18) and CAD (standardized b=0.47; P=0.17; Figure 3).
Also, on multivariable regression, SA ethnicity was the
strongest signiﬁcant predictor of increased LADI among all
variables (standardized b=0.20; P<0.001). Similar to E/e0, the
relationship between age and LADI was polynomial, with linear
(F statistics 91; P<0.001) and quadratic (F statistics 4;
P=0.04) components. On polynomial regression, SA ethnicity
was associated with higher LADI for the whole model
(standardized b=0.20; P<0.001) and for all age groups
presented (P<0.001 for all; Figure 4). There was no signiﬁcant
interaction between age and ethnicity in their relation to LADI
(standardized b=0.07 for interaction; P=0.41; Figure 5). SA
ethnicity was strongly associated with increased LADI already
at the youngest test age (ie, 45 years), and the association
remain throughout the whole included age range.
After a median follow-up of 5.8 years (IQR, 5.2–6.5), 241
(5.3%) participants died from any cause. On multivariable Cox
regression analysis without adjustment for E/e0, independent
predictions of mortality were SA ethnicity, advanced age,
history of CAD and smoking, higher heart rate, BMI, and use
of diuretics (Table 4). After additional adjustment for E/e0,
ethnicity lost its statistical signiﬁcance, whereas E/e0 was
independently predictive of higher risk of death (other
signiﬁcant predictors remained unchanged). When the same
model was ﬁtted with dichotomized E/e0, values of E/e0 ≥10
were independently associated with higher risk of death
(hazard ratio [HR], 1.34; 95% CI, 1.04–1.83; P=0.027;
Figure 6).
Figure 1. Relationship between age and E/e0 in ethnic groups.
The ﬁgure presents multivariable polynomial regression showing
predictive value of ethnicity for E/e0 across the different age
groups. The analysis is based on the model presented in Table 2,
with an additional adjustment of the polynomial component of
age-related effects. Also, age was categorized by groups with 5-
year increments, which are presented as the graph points. Error
bars are 95% CIs for the correspondent graph points.







SBP 0.040.003 0.22 <0.001
Age 0.060.01 0.20 <0.001
Female 1.270.11 0.19 <0.001
LVMI 0.010.001 0.11 <0.001
South Asian origin 0.660.10 0.10 <0.001
Diabetes mellitus 0.680.11 0.09 <0.001
DBP 0.030.01 0.09 <0.001
History of smoking 0.370.11 0.05 0.001
Waist 0.010.01 0.04 0.04
CAD 0.380.18 0.03 0.03
Beta-blockers 0.320.16 0.03 0.04
CAD indicates coronary artery disease; DBP, diastolic blood pressure; LVMI, Left
ventricular mass index; SBP, systolic blood pressure.
For the model, adjusted R2=0.21, P<0.001.
Figure 2. Interactions of age and ethnicity for prediction for E/e0.
Point estimates are values of the regression line at age groups
categorized by 5-year increments. Error bars are 95% CIs for the
correspondent graph points.
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The study shows, for the ﬁrst time, that SAs have accelerated
cardiac aging, as suggested by changes in E/e0. When E/e0 is
used as a surrogate of premature aging after adjustment for
risk factors, diastolic dysfunction, and chronological aging,
the study ﬁndings provide some explanation on why people of
SA origin have increased cardiovascular risk even after






Error Standardized b P Value
Diabetes mellitus*
Present 878 441 1.530.23 0.19 <0.001
Not present 2002 1219 0.350.20 0.57 <0.001
CAD†
Present 311 86 1.260.54 0.12 0.02
Not present 2569 1574 0.6110 0.09 <0.001
CAD indicates coronary artery disease.
*Variables included in the multivariable analysis: age, sex, history of smoking, systolic and diastolic blood pressure, heart rate, body mass index, waist circumference, and left ventricular
mass index.
†
Variables included in the multivariable analysis: age, sex, history of diabetes mellitus and smoking, systolic and diastolic blood pressure, heart rate, body mass index, waist circumference,
and left ventricular mass index.
Figure 3. Interactions of age and ethnicity for prediction for E/e0 in subgroups. A, Without diabetes mellitus (SA, n=2002; AC, n=1219).
B, With diabetes mellitus (SA, n=878; AC, n=441). C, Without coronary artery disease (SA, n=2569; AC, n=1574). D, With coronary artery
disease (SA, n=311; AC, n=86). Point estimates are values of the regression line at age groups categorized by 5-year increments. Error
bars are 95% CIs for the correspondent graph points. AS indicates African-Caribbean origin; SA, South Asian origin.
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accounting for standard cardiovascular risk factors.10,11
Indeed, SAs reached E/e0 of 8, a value commonly considered
as a cutoff for normal range, at a younger mean age of
7.1 years compared to ACs (ie, an ethnic group with an
excellent longevity proﬁle in the UK).13
Evidence of high clinical signiﬁcance of even mild diastolic
dysfunction with relatively low E/e0 comes from the Olmsted
population-based study of subjects aged ≥45 years, where
mild diastolic dysfunction with E/e0 <10 was present in 21%
of participants and was strongly and independently predictive
of all-cause mortality (HR, 8.31; 95% CI, 3.00–23.1;
P<0.001).28 In our study, there was a highly signiﬁcant
interaction between SA ethnicity and the age-related increase
in E/e0. This means than SA had much more prominent
acceleration in the E/e0 elevation with advanced age
compared to ACs. In fact, E/e0 of 9 was reached, on average,
15.4 years younger than ACs. Although these relatively low
E/e0 values may not signify a clinically relevant increase in LV
ﬁlling pressure in healthy subjects, they may signiﬁcantly
contribute to development of cardiac complications in people
with predisposing factors, such as hypertension and CAD.
Moreover, E/e0 was independently predictive of an
increased risk of death, and SA ethnicity lost its independent
predictive value for mortality after adjustment for E/e0. This,
again, supports clinical relevance of accelerated aging in SAs
reﬂected by E/e0 as a prognosticator.
At present, there are no universally accepted clinical
markers of cardiac aging. Although many cardiac parameters
show changes in with age (eg, increase in LV dimensions and
wall thickness), it is difﬁcult to distinguish contributions of
aging per se from those related to age-related changes in
blood pressure or hemoglobin levels, given that the observed
age-related changes are usually small. Among all age-related
cardiac changes, shifts in parameters of diastolic function (eg,
E/A mitral ﬂow ratio) are most prominent and widely
acknowledged. However, many parameters of diastolic dys-
function change bidirectionally with progression of diastolic
dysfunction. For example, E/A decreases and isovolumic
relaxation time and early mitral inﬂow deceleration time
increase in mild diastolic dysfunction, whereas opposite
changes are observed in more-advanced stages. This makes
analysis of continuity of the changes problematic. E/e0 offers
the advantage of unidirectional, relatively linear changes with
increase in LV ﬁlling pressure, and E/e0 has a clear relation to
aging in healthy subjects.29
In order to minimize the effect of age-related hemodymanic
changes (eg, gradual increase in BP even in healthy subjects),
we constructed regression models adjusted for history of
hypertension, BP, and, most important, LVMI. Unsurprisingly,
LVMI itself was strongly predictive for higher E/e0 and
mortality, but adjustment for this parameter lets us speculate
that the observed ethnic differences occurred attributed to
other mechanisms that result in delayed myocardial relaxation
secondary to thickened myocardium. Indeed, this observation
points toward age-related modulation of cardiac extracellular
matrix (ie, ﬁbrosis) or diminished elastic properties/relaxation
speed of cardiomyocytes.
Although there were no signiﬁcant interactions between
ethnicity and diabetes mellitus or CAD in prediction of E/e0 on
regression analysis, and SA origin was uniformly linked to
higher E/e0 in people with or without diabetes mellitus or
CAD, subgroup analyses showed that interactions between
ethnicity and age were largely conﬁned to subjects without
diabetes mellitus or CAD. It is likely (and not unexpected) that
the magnitude of diabetes mellitus/CAD-induced cardiac
Figure 4. Relationship between age and left atrial diameter
index (LADI) in ethnic groups. Point estimates are values of the
regression line at age groups categorized by 5-year increments.
Error bars are 95% CIs for the correspondent graph points.
Figure 5. Interactions of age and ethnicity for prediction for left
atrial diameter index (LADI). P value for interaction. Point
estimates are values of the regression line at age groups
categorized by 5-year increments. Error bars are 95% CIs for the
correspondent graph points.
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changes reﬂected by E/e0 was more substantial compared to
more-subtle effects of aging. A substantially bigger population
would be required to speciﬁcally assess contribution of aging
to cardiac changes in individuals with overt heart disease or
diabetes mellitus.
In support of E/e0-based conclusions, SA origin was a
strong independent predictor of larger left atrial size across all
tested age groups. However, the pattern of age-related effects
was different from those observed for E/e0. Whereas ethnic
difference in E/e0 was relatively modest at the youngest
tested age and SAs had a clear acceleration of E/e0 elevation
with more-advanced age, prominent ethnic differences were
already observed for LADI age 45 years and the magnitude of
these changes remained constant in older people. The precise
explanations of differences are not clear, but they could be
attributed to a larger number of hemodynamic inﬂuences for
atrial size.
Limitations
Because of lack of accepted clinical markers of cardiac aging,
E/e0 was used as a surrogate measure of aging. It was beyond
the scope of the present work to provide mechanistic insights
into the background processes of aging. The analysis of
association of SA ethnicity with premature aging was based
on observational study, and a prospective analysis would
ideally be required. Although E/e0 is accepted as a noninva-
sive measure of LV ﬁlling pressures, recent studies found that
the correlation between E/e0 and pulmonary capillary wedge
pressure may be worse than previously reported, and a novel,
more-advanced echocardiographic technique may be a prefer-
able choice for future research.30–33
Perspectives
People of SA origin are at increased risk of cardiovascular
morbidity and mortality. This cannot be fully explained by their
proﬁle of standard cardiovascular risk factors. SAs often
present with cardiac pathology at a younger age than other
ethnic groups. Premature cardiac aging is evident in SAs and
may contribute to high cardiovascular morbidity in this ethnic
group, compared to ACs. This opens a new direction in the
understanding of “unexplained” excess in cardiac morbidity in
certain populations. Further mechanistic studies are needed
to provide insights into mechanisms of cardiac aging in SAs.
Scarce methods for quantiﬁcation of cardiac senescence are
available at present, and this study encourages further
development in the ﬁeld.
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